The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.

Trial Profile

The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2016

At a glance

  • Drugs Trelagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 25 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top